GSA Capital Partners »

Bioxcel Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $192k 120k 1.60

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Bioxcel Therapeutics

Millennium Management
Vanguard Group
Oaktree Capital Management
Geode Capital Management
FMR
Jane Street
GSA Capital Partners
BlackRock
State Street Corporation
Man Group
Oaktree Fund Advisors
HighTower Advisors
Northern Trust
UBS Group
Jones Financial Companies, L.L

View all funds holding Bioxcel Therapeutics